Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Harper-Wynne

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
Breast cancerAlistair Ring, Catherine Harper-Wynne, Ian Smith
European Journal of Cancer (Oxford, England : 1990)|May 13, 2011
Hormone replacement therapy and women with premature menopause--a cancer survivorship issueJudy King, Catherine Harper Wynne, Laura Assersohn, et al.
Lung Cancer (Amsterdam, Netherlands)|May 29, 2004
Severe acute interstitial pnuemonia and gefitinibKate Sumpter, Catherine Harper-Wynne, Mary O'Brien, et al.
BMJ Case Reports|November 11, 2018
Bronchoalveolar carcinoma as an unsuspected cause for worsening shortness of breath in a patient with metastatic breast cancerSukhdeep Kaur Nagpal, Michael Flynn, Claire Ryan, et al.
Breast Cancer Research and Treatment|May 13, 2025
A disease registry study to prospectively observe treatment patterns and outcomes in patients with HER2-positive unresectable LA/MBC: final results of the ESTHER studyAlistair Ring, Stephanie Sutherland, Catherine Harper-Wynne, et al.
Lung Cancer (Amsterdam, Netherlands)|May 29, 2004
Is the second line data on the use of docetaxel in non-small cell lung cancer reproducible?Kate Sumpter, Catherine Harper-Wynne, Cheng Yeoh, et al.
Nature Reviews. Clinical Oncology|September 3, 2010
Rechallenging with anthracyclines and taxanes in metastatic breast cancerCarlo Palmieri, Jonathan Krell, Colin R James, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 9, 2002
Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer preventionCatherine Harper-Wynne, Gillian Ross, Nigel Sacks, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2008
Impact of estrogen deprivation on gene expression profiles of normal postmenopausal breast tissue in vivoAnne Kendall, Helen Anderson, Anita K Dunbier, et al.
Breast Cancer Research and Treatment|October 8, 2020
Enhanced axillary assessment using intradermally injected microbubbles and contrast-enhanced ultrasound (CEUS) before neoadjuvant systemic therapy (NACT) identifies axillary disease missed by conventional B-mode ultrasound that may be clinically relevantKarina Cox, Nicky Dineen, Sian Taylor-Phillips, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
Breast cancerAlistair Ring, Catherine Harper-Wynne, Ian Smith
European Journal of Cancer (Oxford, England : 1990)|May 13, 2011
Hormone replacement therapy and women with premature menopause--a cancer survivorship issueJudy King, Catherine Harper Wynne, Laura Assersohn, et al.
Lung Cancer (Amsterdam, Netherlands)|May 29, 2004
Severe acute interstitial pnuemonia and gefitinibKate Sumpter, Catherine Harper-Wynne, Mary O'Brien, et al.
BMJ Case Reports|November 11, 2018
Bronchoalveolar carcinoma as an unsuspected cause for worsening shortness of breath in a patient with metastatic breast cancerSukhdeep Kaur Nagpal, Michael Flynn, Claire Ryan, et al.
Breast Cancer Research and Treatment|May 13, 2025
A disease registry study to prospectively observe treatment patterns and outcomes in patients with HER2-positive unresectable LA/MBC: final results of the ESTHER studyAlistair Ring, Stephanie Sutherland, Catherine Harper-Wynne, et al.
Lung Cancer (Amsterdam, Netherlands)|May 29, 2004
Is the second line data on the use of docetaxel in non-small cell lung cancer reproducible?Kate Sumpter, Catherine Harper-Wynne, Cheng Yeoh, et al.
Nature Reviews. Clinical Oncology|September 3, 2010
Rechallenging with anthracyclines and taxanes in metastatic breast cancerCarlo Palmieri, Jonathan Krell, Colin R James, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 9, 2002
Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer preventionCatherine Harper-Wynne, Gillian Ross, Nigel Sacks, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2008
Impact of estrogen deprivation on gene expression profiles of normal postmenopausal breast tissue in vivoAnne Kendall, Helen Anderson, Anita K Dunbier, et al.
Breast Cancer Research and Treatment|October 8, 2020
Enhanced axillary assessment using intradermally injected microbubbles and contrast-enhanced ultrasound (CEUS) before neoadjuvant systemic therapy (NACT) identifies axillary disease missed by conventional B-mode ultrasound that may be clinically relevantKarina Cox, Nicky Dineen, Sian Taylor-Phillips, et al.
Pageof 3